Effects of Chinese Liquors on Cardiovascular Disease Risk Factors in Healthy Young Humans

Table 4

Fasting concentrations of cardiovascular disease risk factors before and after the intervention in male subjects.

Variables	TFL-male (𝑛=12)			TCL-male (𝑛=11)			𝑃 value
	Day 0	Day 28	Difference; (95% CIs)	Day 0	Day 28	Difference; (95% CIs)	Time	Liquor	Time × Liquor
Body weight (kg)	63.25±5.25	63.33±5.09	0.08; (−0.97, 1.14)	65.05±6.66	64.73±6.48	−0.32; (−1.10, 0.47)	0.702	0.52	0.514
HDL-C (mmol/L)	1.31±0.21	1.28±0.24	−0.04; (−0.11, 0.04)	1.49±0.33	1.45±0.29	−0.04; (−0.14, 0.05)	0.16	0.118	0.913
LDL-C (mmol/L)	2.23±0.79	2.05±0.72	−0.18; (−0.38, 0.02)	2.37±0.65	2.10±0.58	−0.28; (−0.45, −0.11)^**	0.001	0.737	0.406
TC (mmol/L)	4.18±0.93	3.68±0.70	−0.50; (−0.82, −0.19)^**	4.48±0.72	3.96±0.60	−0.52; (−0.71, −0.34)^**	<0.001	0.353	0.917
HDL-C/LDL-C	0.69±0.36	0.74±0.42	0.05; (0, 0.11)	0.67±0.20	0.74±0.21	0.07; (0.01, 0.12)^*	0.003	0.934	0.676
TC/HDL-C	3.25±0.82	2.98±0.82	−0.27; (−0.38, −0.16)^**	3.08±0.65	2.79±0.58	−0.28; (−0.39, −0.17)^**	<0.001	0.565	0.86
TG (mmol/L)	1.02±0.42	0.86±0.26	−0.16; (−0.31, −0.02)^*	0.79±0.19	0.81±0.42	0.02; (−0.17, 0.21)	0.202	0.299	0.108
Apo A1 (g/L)	1.33±0.14	1.36±0.17	0.03; (−0.06, 0.11)	1.40±0.24	1.50±0.20	0.10; (0, 0.19)^*	0.04	0.175	0.252
Apo B (g/L)	0.51±0.16	0.52±0.12	0.003; (−0.07, 0.08)	0.53±0.10	0.51±0.16	−0.01; (−0.08, 0.06)	0.871	0.925	0.761
Apo B/A1	0.39±0.12	0.39±0.10	−0.004; (−0.05, 0.04)	0.39±0.12	0.35±0.11	−0.04; (−0.08, 0.01)	0.132	0.667	0.217
DBP (mmHg)	73.50±9.97	77.92±5.42	4.42; (−0.47, 9.30)	70.91±7.30	74.55±8.89	3.64; (−1.78, 9.06)	0.023	0.323	0.815
SBP (mmHg)	119.67±10.47	111.17±7.51	−8.50; (−12.35, −4.65)^**	114.36±11.40	111.45±4.93	−2.91; (−10.42, 4.61)	0.006	0.448	0.146
Glucose (mmol/L)	5.23±0.24	4.89±0.25	−0.34; (−0.55, −0.12)^**	5.09±0.28	4.81±0.26	−0.27; (−0.51, −0.03)^*	<0.001	0.188	0.672
Insulin (μIU/mL)	4.50±1.75	4.90±1.41	0.40; (−0.93, 1.73)	3.77±2.36	5.93±2.12	2.16; (0.34, 3.99)^*	0.019	0.811	0.094
HOMA	1.04±0.40	1.07±0.32	0.02; (−0.29, 0.34)	0.86±0.54	1.28±0.48	0.42; (0, 0.84)	0.073	0.932	0.108
Uric acid (μmol/L)	410.08±61.27	371±25.87	−39.08; (−75.21, −2.94)^*	387.16±52.46	326.83±34.31	−60.34; (−85.58, −35.10)^**	<0.001	0.051	0.307
Hs-CRP (mg/L)	0.94±0.47	1.03±0.41	0.09; (−0.31, 0.49)	0.83±0.42	1.06±0.57	0.23; (−0.04, 0.50)	0.144	0.817	0.527

TFL: tea-flavor liquor; TCL: traditional Chinese liquor; TG: triacylglycerol; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; ApoA1: apolipoprotein A1; ApoB: apolipoprotein B; DBP: diastolic blood pressure; SBP: systolic blood pressure; HOMA: Homeostasis Model Assessment. ^∗𝑃<0.05, compared to day 0 for each intervention; ^∗∗𝑃<0.01, compared to day 0 for each intervention.